BR112012030587A2 - métodos para diagnóstico de câncer pancreático, para identificar se um indivíduo precisa ou não de uma terapia contra câncer pancreático e para determinar se uma terapia contra câncer pancreático obtém sucesso, dispositivo para diagnóstico de câncer pancreático e uso de pelo menos um biomarcador - Google Patents

métodos para diagnóstico de câncer pancreático, para identificar se um indivíduo precisa ou não de uma terapia contra câncer pancreático e para determinar se uma terapia contra câncer pancreático obtém sucesso, dispositivo para diagnóstico de câncer pancreático e uso de pelo menos um biomarcador

Info

Publication number
BR112012030587A2
BR112012030587A2 BR112012030587A BR112012030587A BR112012030587A2 BR 112012030587 A2 BR112012030587 A2 BR 112012030587A2 BR 112012030587 A BR112012030587 A BR 112012030587A BR 112012030587 A BR112012030587 A BR 112012030587A BR 112012030587 A2 BR112012030587 A2 BR 112012030587A2
Authority
BR
Brazil
Prior art keywords
pancreatic cancer
diagnosing
cancer therapy
biomarker
methods
Prior art date
Application number
BR112012030587A
Other languages
English (en)
Inventor
Beate Kamlage
Bodo Schniewind
Holger Kalthoff
Julia Mayerle
Markus Lerch
Martin Kluttig
Regina Reszka
Original Assignee
Ernst Moritz Arndt Universität
Metanomics Health Gmbh
Universitätsklinikum Schleswig Holstein
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ernst Moritz Arndt Universität, Metanomics Health Gmbh, Universitätsklinikum Schleswig Holstein filed Critical Ernst Moritz Arndt Universität
Publication of BR112012030587A2 publication Critical patent/BR112012030587A2/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57438—Specifically defined cancers of liver, pancreas or kidney
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
BR112012030587A 2010-06-01 2011-05-26 métodos para diagnóstico de câncer pancreático, para identificar se um indivíduo precisa ou não de uma terapia contra câncer pancreático e para determinar se uma terapia contra câncer pancreático obtém sucesso, dispositivo para diagnóstico de câncer pancreático e uso de pelo menos um biomarcador BR112012030587A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US35004210P 2010-06-01 2010-06-01
EP10164624 2010-06-01
PCT/EP2011/058670 WO2011151252A2 (en) 2010-06-01 2011-05-26 Means and methods for diagnosing pancreatic cancer in a subject

Publications (1)

Publication Number Publication Date
BR112012030587A2 true BR112012030587A2 (pt) 2017-01-24

Family

ID=44626935

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112012030587A BR112012030587A2 (pt) 2010-06-01 2011-05-26 métodos para diagnóstico de câncer pancreático, para identificar se um indivíduo precisa ou não de uma terapia contra câncer pancreático e para determinar se uma terapia contra câncer pancreático obtém sucesso, dispositivo para diagnóstico de câncer pancreático e uso de pelo menos um biomarcador

Country Status (10)

Country Link
US (1) US20130140452A1 (pt)
EP (3) EP3355057A3 (pt)
JP (3) JP5930412B2 (pt)
KR (1) KR101894111B1 (pt)
CN (3) CN105785003B (pt)
AU (2) AU2011260390B2 (pt)
BR (1) BR112012030587A2 (pt)
CA (1) CA2800023A1 (pt)
IL (1) IL223147B (pt)
WO (1) WO2011151252A2 (pt)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3502707A1 (en) 2010-01-29 2019-06-26 metanomics GmbH Means and methods for diagnosing heart failure in a subject
CN106526186A (zh) 2011-09-12 2017-03-22 克里蒂科斯有限责任公司 检测靶分子的非侵入性方法
WO2013079594A1 (en) * 2011-11-30 2013-06-06 Metanomics Health Gmbh Device and methods to diagnose pancreatic cancer
EP2815236A4 (en) * 2012-02-15 2015-11-04 Basf Se MEANS AND METHODS FOR ASSESSING ENDOCRINE DISEASE OR ENDOCRINE DISORDER
US20130316462A1 (en) * 2012-05-25 2013-11-28 Health Diagnostic Laboratory, Inc. Rapid and high-throughput analysis of sterols/stanols or derivatives thereof
CA2874738A1 (en) * 2012-05-25 2013-11-28 Health Diagnostic Laboratory, Inc. Process and apparatus for rapid, high-throughput analysis of fatty acids
JP6299063B2 (ja) * 2012-11-27 2018-03-28 味の素株式会社 膵臓癌リスク疾患の評価のための方法、膵臓癌リスク疾患評価装置、膵臓癌リスク疾患評価方法、膵臓癌リスク疾患評価プログラムおよび膵臓癌リスク疾患評価システム
CA2902841A1 (en) * 2013-03-13 2014-10-02 Creatics Llc Methods and compositions for detecting pancreatic cancer
GB201314485D0 (en) * 2013-08-13 2013-09-25 Electrophoretics Ltd Materials and methods relating to pancreatic cancer
EP3084443B1 (en) 2013-12-20 2018-08-22 Metanomics Health GmbH Means and methods for diagnosing pancreatic cancer in a subject based on a metabolite panel
EP3006453A1 (en) 2014-10-08 2016-04-13 Cosmo Technologies Ltd. 17alpha-monoesters and 17alpha,21-diesters of cortexolone for use in the treatment of tumors
CN105572276B (zh) * 2014-11-07 2018-12-18 上海市第六人民医院 胰腺癌诊断标记物组合、应用及其测定方法
CA2990316A1 (en) 2015-06-25 2016-12-29 Metanomics Health Gmbh Means and methods for diagnosing pancreatic cancer in a subject based on a biomarker panel
JP2017067510A (ja) * 2015-09-29 2017-04-06 花王株式会社 脂質の質量分析方法
EP3502699A1 (en) 2017-12-20 2019-06-26 Metanomics Health GmbH Methods for diagnosing pancreatic cancer
JP7086417B2 (ja) 2018-01-22 2022-06-20 ウニベルシタ パルドゥビツェ 体液のリピドミクス解析に基づいて癌を診断する方法
PT3514545T (pt) 2018-01-22 2021-01-12 Univ Pardubice Um método de diagnóstico de cancro pancreático baseado na análise lipidómica de um fluido corporal
WO2019211767A1 (en) * 2018-05-02 2019-11-07 Waters Technologies Corporation Methods for authenticating botanicals using a marker compound's related chromatographic profile and mass spectral profile jointly
FI3575793T3 (fi) 2018-05-29 2023-09-11 Fons Jk Group A S Menetelmä syövän diagnosoimiseksi kehonnesteen lipidomisen analyysin perusteella
KR102070916B1 (ko) * 2018-08-31 2020-01-29 연세대학교 산학협력단 췌장암 환자의 예후를 예측하기 위한 바이오마커 및 이의 용도
KR102239206B1 (ko) * 2019-03-06 2021-04-12 연세대학교 산학협력단 절제술 효과 평가 장치 및 시스템
ES2799973A1 (es) * 2019-06-19 2020-12-22 Univ Granada Panel de metabolitos como biomarcadores para el diagnostico de cancer de pancreas
CN111662982B (zh) * 2020-06-09 2022-06-03 山东大学齐鲁医院 用于脑胶质瘤早期诊断和/或复发监测的生物标志物及其应用

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4540884A (en) 1982-12-29 1985-09-10 Finnigan Corporation Method of mass analyzing a sample by use of a quadrupole ion trap
US5397894A (en) 1993-05-28 1995-03-14 Varian Associates, Inc. Method of high mass resolution scanning of an ion trap mass spectrometer
JPH0658939A (ja) * 1992-08-06 1994-03-04 Tosoh Corp 癌の診断方法および医薬品組成物
CA2457437A1 (en) * 2001-08-03 2003-02-20 Biotron Limited A novel cancer marker and uses therefor in the diagnosis of cancer
EP1481416B1 (de) 2002-02-28 2016-06-15 Metanomics GmbH & Co. KGaA Massenspektrometrisches verfahren zur analyse von substanzgemischen
ES2320443T3 (es) * 2002-09-30 2009-05-22 Oncotherapy Science, Inc. Genes y polipeptidos relacionados con canceres pancreaticos humanos.
AU2005251463A1 (en) * 2004-06-14 2005-12-22 Zoser B. Salama Anti-cancer composition comprising proline or its derivatives and an anti-tumour antibody
JP5200246B2 (ja) 2005-03-14 2013-06-05 財団法人ヒューマンサイエンス振興財団 膵臓癌診断用マーカータンパク質
JPWO2006098192A1 (ja) * 2005-03-16 2008-08-21 味の素株式会社 生体状態評価装置、生体状態評価方法、生体状態評価システム、生体状態評価プログラム、評価関数作成装置、評価関数作成方法、評価関数作成プログラムおよび記録媒体
EP1991872A1 (en) * 2006-03-02 2008-11-19 Oncotherapy Science, Inc. Methods for diagnosing pancreatic cancer using reg4 protein
US7611902B2 (en) * 2006-06-12 2009-11-03 Zora Biosciences Oy Diagnostic method for myopathy
US20100092476A1 (en) * 2006-11-17 2010-04-15 Hanash Samir M Pancreatic cancer biomarkers
EP2103941A4 (en) * 2006-12-21 2010-10-20 Ajinomoto Kk METHOD FOR EVALUATING CANCER, CANCER EVALUATION DEVICE, METHOD, SYSTEM, PROGRAM AND RECORDING MEDIUM
CN101960310A (zh) * 2008-03-04 2011-01-26 味之素株式会社 癌症种类的评价方法
WO2009153136A2 (en) * 2008-05-28 2009-12-23 Basf Se Means and methods for assessing liver toxicity
US20120004854A1 (en) * 2008-05-28 2012-01-05 Georgia Tech Research Corporation Metabolic biomarkers for ovarian cancer and methods of use thereof
DE112009001703T5 (de) * 2008-07-15 2011-05-19 Inserm Institute National De La Sante Et De La Recherche Medicale Mittel und Verfahren zur Diagnostik von Magenbypass und damit verbundenen Zuständen
JP2010038796A (ja) * 2008-08-06 2010-02-18 Human Metabolome Technologies Inc 疾患マーカー、および、疾患マーカーの測定方法
US20120165217A1 (en) * 2008-10-06 2012-06-28 Somalogic, Inc. Cancer Biomarkers and Uses Thereof
CN101613748A (zh) * 2009-06-09 2009-12-30 中国人民解放军第二军医大学 一种检测胰腺癌血清标志物的方法
EP2483697B2 (en) * 2009-10-01 2017-07-05 Phenomenome Discoveries Inc. Method to diagnose pancreatic cancer

Also Published As

Publication number Publication date
AU2011260390A8 (en) 2013-06-06
CN103038644A (zh) 2013-04-10
CN105785003B (zh) 2018-09-07
EP3546945A1 (en) 2019-10-02
CA2800023A1 (en) 2011-12-08
AU2011260390B2 (en) 2016-11-24
AU2017201020B2 (en) 2018-07-19
CN105785003A (zh) 2016-07-20
IL223147B (en) 2018-04-30
IL223147A0 (en) 2013-02-03
CN108872579A (zh) 2018-11-23
US20130140452A1 (en) 2013-06-06
WO2011151252A3 (en) 2012-04-19
EP3355057A3 (en) 2018-12-12
JP2013527464A (ja) 2013-06-27
AU2011260390A1 (en) 2013-01-10
EP2577314B1 (en) 2018-01-31
KR20130119335A (ko) 2013-10-31
KR101894111B1 (ko) 2018-08-31
JP2016148678A (ja) 2016-08-18
JP6286475B2 (ja) 2018-02-28
EP2577314A2 (en) 2013-04-10
CN103038644B (zh) 2016-03-09
JP2018066765A (ja) 2018-04-26
WO2011151252A2 (en) 2011-12-08
JP5930412B2 (ja) 2016-06-08
AU2017201020A1 (en) 2017-03-09
EP3355057A2 (en) 2018-08-01

Similar Documents

Publication Publication Date Title
BR112012030587A2 (pt) métodos para diagnóstico de câncer pancreático, para identificar se um indivíduo precisa ou não de uma terapia contra câncer pancreático e para determinar se uma terapia contra câncer pancreático obtém sucesso, dispositivo para diagnóstico de câncer pancreático e uso de pelo menos um biomarcador
HK1226482B (zh) 胰腺癌用唾液生物標記物以及使用了胰腺癌用唾液生物標記物的胰腺癌的診斷方法
WO2014160499A3 (en) Methods and compositions for detecting pancreatic cancer
BR112014018831A2 (pt) método para otimizar sensibilidade e/ou seletividade de um sensor para um ou mais analitos, método para formar um sensor para um ou mais analitos, kit para a detecção de um ou mais analitos, método de identificação de um aptâmero, composição de matéria e aptâmeros.
EP2817617A4 (en) DEVICES, METHODS AND TEST KITS FOR ELECTRONIC ANALYTE ASSAY
BR112014031365A2 (pt) métodos de detectar doenças ou condições
BR212012003383U2 (pt) sola com ferragens articuladas em sua periferia.
TN2013000464A1 (en) Biomarkers for hedgehog inhibitor therapy
MX340453B (es) Biomarcadores para cancer de pulmon.
BR112013013471A2 (pt) sistema de painel solar, kit de painel solar e método para determinar um estado operacional de um painel solar
BR112014002616A2 (pt) método para detectar cãncer pancreático e reagente ou kit para detectar câncer pancreático
BR112014018995A2 (pt) Sistemas para executar ensaio automatizado
BR112013014990A2 (pt) dispositivo de medição, dispositivo de controle e aparelho de medição para medição de nível de enchimento
GB201305223D0 (en) Reflection detection type measurement apparatus for skin autofluorescence
HK1209863A1 (en) Systems and methods for generating biomarker signatures with integrated dual ensemble and generalized simulated annealing techniques
BR112015003046A2 (pt) sistema de neurofeedback, processador de sinal para determinação de uma característica do sinal do sinal do biofeedback medido, método para provisão de um usuário com o neurofeedback e programa de computador.
EP2971132A4 (en) FABRIC AND BLOOD-BASED MIRNA BIOMARKERS FOR THE DIAGNOSIS, FORECASTING AND PREDICTING THE METASTAS POTENTIAL IN COLOR LECTAL CANCER
BR112013015930A2 (pt) método para analisar pelo menos um fragmento emergindo de um poço, e conjunto para analisar pelo menos um fragmento emergindo de um poço.
BRPI1015922A2 (pt) sistemas e métodos para testar analitos
BR112012002954A2 (pt) metodo para diagnosticar um disturbio de tireoide, metodo para determinar a capacidade de um composto de induzir um disturbio da tireoide metodo para identificar uma substancia para tratar um disturbio da tireoide, dispositivo para diagnosticar um disturbio da tireoide e uso de pelo menos um analito
ITRM20120383A1 (it) Metodo e kit per la rivelazione di anticorpi.
EP3176268A4 (en) Novel biomarker for predicting sensitivity to egfr-targeting agent, and use thereof
BR112013030886A2 (pt) método, reagente e kit para medir hemoglobina glicada.
BR112014030707A2 (pt) dispositivo obturador para um painel de computadores elétricos , e painel de computadores relacionado.
EP2825673A4 (en) METHOD, KIT AND CHIP FOR BIOMARKER VALIDATION AND CLINICAL USE

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06T Formal requirements before examination [chapter 6.20 patent gazette]
B11E Dismissal acc. art. 34 of ipl - requirements for examination incomplete
B11T Dismissal of application maintained [chapter 11.20 patent gazette]